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The emergency use of endografts in the carotid
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We report our experience with the use of endoluminal grafts to control emergency bleeding in two patients with
tracheoinnominate fistulas and three patients with carotid blowouts. Systemic infectious complications were not seen.
However, rebleeding occurred in one patient, and extensive stent coverage to control bleeding was required in a second.
Survival was usually limited by the patient’s cancer. There was one long-term survivor without cancer whose tracheos-
tomy was placed for neurologic compromise. A review of the literature for similar cases identified 18 additional
endografts placed for carotid blowout and 3 placed for tracheoinnominate fistulas. Overall, infectious complications
occurred in only two patients, whereas rebleeding occurred in eight patients. On the basis of these findings, we believe
that endografts are useful to control emergency hemorrhage in these two pathologies because treatment is usually
palliative, given the poor survival secondary to the underlying disease. However, more extensive graft coverage may be
necessary considering the erosive nature of these processes. ( J Vasc Surg 2007;46:792-8.)Tracheoinnominate fistulas and carotid blowouts are
two erosive pathologies in the carotid circulation associated
with devastating complications. Open repair of either entity
has been associated with mortality rates approaching
50%.1,2 In addition, the postoperative stroke rate among
patients who survive open ligation for carotid blowout has
been estimated to be as high as 60%.2 In light of these
findings, endovascular interventions have been proposed as
an alternative to open intervention. The use of covered
stents is one such intervention that has been reported, with
varying outcomes. Covered stents are an attractive alterna-
tive for many reasons. These include the ability to rapidly
control hemorrhage from a remote, minimally invasive site
while maintaining cerebral flow. However, this also in-
volves the placement of a prosthetic device in a potentially
infected or contaminated field. Because of the rarity of
these events, there are no large series examining the out-
come of this strategy. Therefore, the purposes of this article
are to report our experience with the emergency use of
endografts in two patients with tracheoinnominate fistulas
and three patients with carotid blowouts and to review the
literature regarding this treatment strategy. The cases re-
ported entail our institution’s total experience with this
approach and occurred between September 2003 and July
2006.
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792CASE REPORTS
Case 1. A 22-year-old female patient presented with inter-
mittent copious bleeding from her tracheostomy. The tracheos-
tomywas placed in early childhood for severe cerebral palsy, mental
retardation, and hydrocephalus. Computed tomographic angiog-
raphy of the neck and chest suggested tracheoinnominate fistula.
Bronchoscopy revealed an erosion of the innominate artery on the
anterior wall of the trachea with evidence of recent bleeding. After
extensive discussion with the family regarding treatment options,
including comfort measures only, a decision for endovascular
repair was reached. Repair was achieved by placing an 8  30 mm
Wallgraft (Boston Scientific, Natick, Mass) in the innominate and
proximal right common carotid artery (CCA) via a 9F sheath after
open exposure of the left femoral artery. In addition, a 5F sheath
was placed percutaneously in the right femoral artery for simulta-
neous angiography to guide placement. Completion angiography
revealed successful control of bleeding with late filling of the right
subclavian artery (Fig 1). After the operation, the patient had no
complications and no further bleeding. She was sent home on
intravenous antibiotics (clindamycin) for 6 weeks. She was alive
without infection at a follow-up of 24 months.
Case 2. A 77-year-old female patient presented with severe
bleeding from her tracheostomy. The tracheostomy was placed 2
months earlier after laryngectomy, central node dissection, and
radiotherapy for anaplastic thyroid carcinoma. Manual pressure
was necessary to control hemorrhage during transport from the
referring hospital. Unfortunately, the patient became increasingly
unstable and was in extremis upon arrival to the operating room.
Expeditious right brachial artery access was obtained by using an
open technique, and a 12F sheath was inserted into the artery.
Retrograde angiography revealed a bovine arch and diffuse bleed-
ing from the innominate artery. A 12  30 mm Wallgraft was
deployed in the innominate artery, and this partially controlled the
hemorrhage. A repeat angiogram showed continued bleeding dis-
tal to the graft from the origin of the right CCA. Percutaneous left
arotid
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right CCAwas selectively cannulated, and a 10 70mmWallgraft
was then deployed as an extension of the innominate stent into the
right CCA. Another 12-mm endograft would have been prefera-
ble, but was not readily available at the time. Regardless, there was
no type III endoleak, and bleeding ceased from the neck at that
point. A 12  20 mm Wallstent (Boston Scientific) was then used
to secure fixation of the 10-mm Wallgraft inside the 12-mm
Wallgraft. Completion angiogram revealed no endoleak and good
flow in the right carotid. An open repair of the left femoral artery,
as well as the right brachial artery, was then performed. An axillary-
axillary bypass was also necessary in this case because of severe
hypoperfusion to the right upper extremity. The patient sustained
a right occipital infarct perioperatively. She was discharged to
hospice on postoperative day 7 with a resolving left hemiparesis.
She died 1 month later from her malignancy.
Case 3. A 51-year-old male patient presented with bleeding
from a recurrent tumor in his left neck. Six months earlier, the
patient had undergone total laryngectomy, tracheostomy, bilateral
neck dissection, and radiotherapy for laryngeal squamous cell
carcinoma. Angiography revealed intense tumor blush fed pre-
dominantly by hypertrophied branches of the left external ca-
rotid artery (ECA). In addition, there was irregularity of the
cervical left internal carotid artery (ICA)—consistent with tu-
mor involvement—as well as adequate cross-filling of the intra-
cranial circulation from the right carotid system. The left ECA
and its branches were embolized with polyvinyl alcohol particles
ranging from 150 to 250 m. However, the patient rebled the
following day. On the basis of the previous day’s angiographic
findings, a decision was made to sacrifice the entire left carotid
system. A 10F sheath was placed percutaneously in the right
femoral artery. An 8  5 cm Viabahn endograft (W.L. Gore &
Associates, Flagstaff, Ariz) was deployed in the left CCA and ECA
to abruptly occlude flow in the ICA. The CCA and ECA were then
embolized with multiple coils. The patient had no postoperative
complications and no further bleeding. He was readmitted 1
month later as a result of dysphagia for which he required laparo-
Fig 1. Intraoperative angiography demonstrating extr
exclusion by an endograft extending into the common cscopic G-tube placement and lysis of abdominal adhesions. Al-though continued tumor erosion led to late exposure of his en-
dograft (Fig 2), he had no systemic infectious complications. He
died 4 months later as a sequela of his cancer.
Case 4. A 61-year-old female patient presented with brisk
arterial bleeding from her left neck. Five years earlier, the patient
had undergone total laryngectomy, radical neck dissection, and
radiotherapy for laryngeal carcinoma. In addition, she had a prior
failed attempt at esophageal reconstruction via free flap. She ar-
rived in the operating room in extremis with severe acidosis; she
was intubated and hypotensive. Angiography revealed bleeding
from the proximal left CCA near the base of the wound. An 8 30
mm Wallgraft was deployed in the left CCA from percutaneous
right femoral access and seated with a 6-mm balloon, resulting in
abrupt control of the bleeding. The femoral artery was then
repaired by an open approach. Pectoralis flap coverage of the neck
wound was then performed by the head and neck surgeons.
However, during that procedure, the patient rebled from distal to
Fig 2. Exposure of an endograft in the tumor bed secondary to
tumor erosion.
tion from the innominate artery (left) and successful
artery with late filling of the subclavian artery (right).avasathe stent. This was controlled by using direct manual pressure
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revealed thrombosis of the initial stent and the left CCA. The
patient recovered uneventfully but died 4months later as a result of
her cancer.
Case 5. A 78-year-old male patient presented with oropha-
ryngeal bleeding and hemoptysis. The patient was status post total
laryngectomy, chemotherapy, and irradiation for laryngeal cancer.
Direct laryngoscopy and bronchoscopy were performed, and these
revealed arterial bleeding from the anterior wall of the esophagus
and necrotic tissue within the esophageal lumen. The esophagus
was packed. Angiography revealed a 2-cm pseudoaneurysm of the
proximal left CCA with extravasation. A 7 mm  5 cm Viabahn
was deployed from right femoral access and seated with an 8-mm
balloon, and this successfully stopped the bleeding. The patient
was discharged on postoperative day 1 but returned 1 week later
with a gastrointestinal hemorrhage. Repeat carotid angiography
confirmed continued exclusion of the carotid-pharyngeal fistula.
The patient died shortly thereafter frommultisystem organ failure.
DISCUSSION
This series illustrates some of the challenges inherent to
the endovascular management of this process. It is interest-
ing to note that in our small series, the most common
difficulty was continued hemorrhage despite apparent ini-
tial control of the offending bleeding site. Systemic infec-
tious complications were not seen in our cohort.
To improve our understanding of the expected out-
comes of this approach, we reviewed the literature for
similar cases. Literature review was performed by using the
PUBMED search engine. Bibliographies from all identified
cases were cross-referenced for identification of additional
cases. Cases were excluded if the endografts were placed for
indications other than active bleeding (eg, stable pseudo-
aneurysm). We identified 18 additional cases of emergency
endografts placed in 17 patients for carotid blowout
(Table I) and 3 additional emergency endografts placed for
tracheoinnominate fistulas (Table II).
Systemic infectious complications were reported in
only 2 of the 21 cases of carotid blowout and in none of the
5 cases of tracheoinnominate fistula. Both of the infectious
complications occurred in patients with pharyngeal in-
volvement of the carotid blowout. Although the numbers
are small, it is reasonable to infer that the higher bacterial
load in such cases may have contributed to the infections.
One of the infectious complications was a wound cellulitis
that resolved with antibiotics. The other was significantly
more morbid, consisting of brain abscess from septic em-
boli. It should be noted that nine additional patients who
had carotid blowout with pharyngeal involvement did not
develop infectious complications. There were also five pa-
tients with delayed transcutaneous exposure of the stent
from continued tumor erosion who did not develop sys-
temic infectious complications. Finally, there were only
three cases in which the administration of prolonged peri-
operative antibiotics was documented. None of these cases
was associated with infectious complications.
Rebleeding, conversely, was a commonly reported
complication in the postoperative course of these patients.Significant rebleeding was seen in eight patients. This does
not include the patient in our series who underwent stent
placement because of rebleeding from the CCA after coil
embolization of the ECA. In addition, case 2 in our series
required additional stent coverage than was expected on
the basis of the initial angiogram. Rebleeding has also been
recognized as frequent complication after embolization of
the carotid for blowout.2 This finding should not be sur-
prising given the erosive nature of lesions. In our experi-
ence, the exact bleeding site is not always easy to localize,
and there is almost certainly a much more diffuse involve-
ment than may be appreciated on angiography. These
findings underscore the importance of more generous cov-
erage of landing zones in these cases as compared with
more discrete processes such as penetrating trauma. We
would recommend covering at least all of the artery that is
involved with tumor.
In terms of other complications, stroke was reported in
six cases (23%) overall. However, three of the strokes were
delayed complications. The periprocedural stroke rate,
therefore, was 12%. Two of the periprocedural strokes were
thromboembolic, and one was a watershed stroke. All three
resolved. The watershed stroke was probably more a result
of the tracheoinnominate fistula itself than a technical
complication from the endograft placement. The patient
was severely hypotensive and hypoxemic for several minutes
just before endograft insertion. In addition, digital com-
pression of the innominate artery was being performed,
thus further compromising cerebral flow. It should also be
noted that two of the three delayed strokes occurred after
subsequent coil embolization procedures performed for
late recurrent bleeding. The remaining stroke occurred as a
result of septic embolism, as previously noted.
Excluding grafts that were intentionally sacrificed by
coil embolization, four grafts occluded. One occlusion
(case 4 in our series) was believed to be due to the manual
compression necessitated by rebleeding in the distal carotid
artery. Only one of these four occlusions resulted in stroke.
Again, this occurred in the patient with the septic emboli.
Postoperative anticoagulation with clopidogrel was docu-
mented in seven patients. None of these patients had graft
occlusion. However, two of the patients rebled.
In terms of patient survival, most patients with carotid
blowout died within months of the event secondary to their
cancer. The longest reported survival in this group was 1
year.
In contrast, three of the five patients with tracheoin-
nominate fistulas have survived with follow-up ranging
from 14 to 24 months. Prior studies on survivors of open
repair of tracheoinnominate fistulas have shown that long-
term survival is uncommon.15 It is interesting to note that
all three of the long-term survivors in this review required
tracheostomy for neurologic compromise, as opposed to
local pathology. This observation may account both for the
improved overall prognosis and for the improved healing at
the endograft implantation site. The presence of cancer and
prior irradiation are known risk factors for wound compli-
cations. Therefore, patients without these risk factors can
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that the only patient in this subgroup who developed
recurrent bleeding had metastatic cancer to the trachea and
irradiation with an assumed primary tracheoinnominate
fistula. Therefore, this patient had a much more aggressive
local pathology compared with the long-term survivors in
the series.
Comparisons of the results presented in this review
with other treatment options is difficult because of the
rarity of these cases and the numerous variables that need to
be taken into account when outcomes are evaluated. This is
especially true for carotid blowout syndrome. For clarifica-
tion, we excluded cases in which the bleeding source was
solely the ECA or one of its branches. In such cases,
selective embolization or ligation of the bleeding or parent
artery could be performed alone without necessarily com-
promising cerebral flow. In addition, we tried to include
only emergency cases performed for active hemorrhage, as
was representative of the five cases at our institution. Un-
fortunately, most large series include cases of threatened or
impending carotid blowout, such as cases of an exposed
carotid artery or a carotid artery pseudoaneurysm.
The first reported case of carotid blowout was in 1962
by Borsany.16 For the most part, standard treatment for the
next two to three decades consisted of ligation. Average
estimates from several heterogenous earlier studies suggest
that both the mortality and major neurologic morbidity
rates are somewhere in the 30% to 50% range.17-22 In a rare
contemporary series, Upile et al23 reported results in 11
patients, noting a 91% 1-month survival, two recurrent
bleeds, and a 27% incidence of major morbidity. However,
the bleeding site was the ECA in six of these patients. The
incidence of major morbidity in the remaining five patients
(ie, those with CCA or ICA involvement) was 60%.
As with most vascular pathologies, most of the recent
literature has focused on endovascular techniques for the
treatment of this disease process. The earliest techniques
involved sacrifice of the involved artery, specifically by the
use of detachable balloons.24,25 Perhaps the largest series
examining this approach, by Chaloupka et al,26 consisted of
23 procedures in 18 patients, with 2 early deaths, 2 tran-
sient ischemic attacks, and no permanent neurologic
events. However, only five patients presented with acute
carotid blowout, and two of these involved the external
carotid system. Of the three patients in their series who
would have met our inclusion criteria, all survived, and
there was one transient ischemic event. Thus, most of the
patients treated with this method were treated on an ur-
gent, rather than emergency, basis. This allowed for test
balloon occlusion before permanent vessel sacrifice. It is
interesting to note that Chaloupka et al2 later reported a
series of 12 patients with recurrent carotid blowout after
endovascular occlusion, again emphasizing the erosive na-
ture of these lesions. Although it is logical to assume that
ablative techniques would decrease the incidence of re-
bleeding, it is important to recognize that they do not
eliminate the problem.Another important consideration is that the detachable
latex balloons used in this study and others are no longer
available in the United States. The current alternative, coil
embolization, poses an additional inherent risk in that flow
is not abruptly ceased during the thrombotic process.
Graves et al27 reported a 26% neurologic complication rate
in 19 patients undergoing elective coil embolization of the
carotid and vertebral arteries with adjuvant proximal bal-
loon occlusion during the placement of the coils. Unfortu-
nately, none of those patients had carotid blowout. Barr
et al28 later reported a 16% neurologic complication rate in
19 patients treated with coil embolization, only 6 of which
had adjuvant proximal balloon occlusion. This series did
include two patients with carotid blowout. It is interesting
to note that both cases required detachable balloons for
complete arrest of hemorrhage, and one of the patients
experienced a fatal stroke. It should be noted that three
cases in our series underwent coil embolization for rebleed-
ing after endograft placement. Stroke occurred in two of
these.
Case 3 represents a novel approach to achieve vessel
occlusion with a combination of a stent graft and coils. As
such, we believe that it deserves separate consideration.
This case was unique in our series in that it was a recurrent
bleed now involving the CCA in a patient who recently
underwent a full cerebrovascular evaluation. As such, we
had the benefit of knowing that the patient’s contralateral
system was dominant. Our technique produced abrupt
occlusion of the ICA, potentially decreasing the risk of
stroke during embolization of the CCA and ECA. Another
reason that we chose that particular approach is that the
current endografts are not tapered, and we were concerned
about infolding of the graft or rupture of the ICA from the
oversizing that would have been necessitated if the en-
dograft were extended into that vessel.
The data on tracheoinnominate fistulas seem more
straightforward. First described in 1879 by Korte,29 tra-
cheoinnominate fistula remains one of the more formidable
challenges in surgery. Gelman et al15 published what many
consider the seminal review of this entity, compiling 71
patients from a review of the literature from 1962 to 1994.
The authors found that only 40 (56%) of these patients
survived more than 2 months. Survival was much greater in
the patients undergoing ligation (71%) than in patients
undergoing revascularization (16%). The most frequent
cause of death in the latter group was recurrent hemorrhage
from suture line failure or infectious complications. Case
reports of reconstruction by using cleaner inflow or targets
(aorto-carotid, aorto-axillary, or extra-anatomic bypass)
suggest fewer infectious complications and rebleeding with
these techniques.30,31 Others have advocated the use of
muscle flaps or autogenous conduits.32-34 In terms of al-
ternative endovascular interventions, there has been one
report of embolization of tracheoinnominate fistula.35 The
case involved a 9-year-old patient with tracheostomy for
encephalopathy. The patient was alive with no further
bleeding episodes at 1 year of follow-up. Finally, Sessa
et al36 reported the use of a stent graft as a temporizing
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Study Clinical history Bleeding site Stent Anticoagulation
Extended
postoperative
antibiotics Outcome
MacDonald
et al3
61-y-old man with
tongue CA, s/p
ND and XRT
Transcutaneous
from R CCA
Jostent NS Yes (10 days) Alive at 5 mo
Kwok et al4 63-y-old man with
oropharyngeal
CA, s/p ND and
XRT
Transpharyngeal
from R CCA
Jostent NS NS Rebled during surgery,
requiring coil
embolization; alive at 2 mo
Warren et al5 67-y-old man with
multiple
oropharyngeal
CA, s/p ND and
XRT
Pharyngocutaneous
from L CCA
Jostent NS NS Rebled at 3 wk, requiring coil
embolization complicated
by CVA; subsequent
exposure of stent; died
several months later
Same patient Pharyngocutaneous
from R CCA
Jostent NS NS Rebled several months later;
died before intervention
44-y-old woman
with multiple CA,
s/p ND, XRT,
and tracheostomy
Transpharyngeal
from origin R
ECA
Jostent NS At 1 mo Cellulitis 1 mo after surgery;
subsequent stent exposure;
died at 4 mo
Bates and
Shamsham6
42-y-old man with
squamous cell CA
of soft palate and
uvula
Transcutaneous
from R ECA
Wallgraft Clopidogrel 1 mo NS Alive at 6 mo
Lesley et al7 54-y-old man with
squamous cell
CA, s/p ND and
XRT
ICA PTFE-
covered
Palmaz
ASA/clopidogrel NS Alive at 3 mo
46-y-old man with
squamous cell
CA, s/p ND
ICA Wallgraft ASA/clopidogrel NS Alive at 3 mo
41-y-old man with
squamous cell
CA, s/p ND and
tracheostomy
Origin ECA Wallgraft ASA/clopidogrel NS Alive at 1 y
Simental et al8 69-y-old woman
with unspecified
CA, s/p XRT
Transcutaneous
from L CCA
Wallgraft NS NS Exposed stent at 3 wk; rebled
at 6 wk, requiring coil
embolization complicated
by CVA and death
47-y-old man with
lingual CA
Transcutaneous
from L CCA
Wallgraft NS NS Gradual exposure of stent
with thrombosis; died at 2
mo
Desuter et al9 Squamous cell CA
of pyriform sinus,
s/p ND and XRT
Transpharyngeal
from ICA
Jostent Abciximab after
CVA
NS Perioperative stroke, resolved
after treatment with
abciximab; died at 7 mo
Squamous cell CA
of pyriform sinus,
s/p XRT and
tracheostomy
Transpharyngeal
from bulb
Fluency Heparin/urokinase
after CVA
NS Perioperative stroke, resolved
after treatment with
heparin and urokinase; alive
at 5 mo
Kim et al10 62-y-old man with
esophageal CA
Transcutaneous
from CCA
Niti-S Clopidogrel NS Rebled at 11 d; alive at 2 mo
57-y-old man with
nasopharyngeal
CA
Transpharyngeal
from bulb
Niti-S Clopidogrel NS Rebled at 6 wk; died at 5 mo
68-y-old man with
laryngeal CA
Transpharyngeal
from CCA
Niti-S Clopidogrel NS Alive at 1 d
61-y-old man with
hypopharyngeal
CA
Transpharyngeal
from bulb
Niti-S Clopidogrel NS Alive at 1 dWallgraft (Boston Scientific, Natick, Mass); Viabahn (W.L. Gore & Assoc., Flagstaff, Ariz); Jostent (Jomed Corporation, Rancho Cordova, Calif); Fluency
(Bard Peripheral Vascular, Tempe, Ariz); Niti-S (Taewoong Medical, Seoul, Korea); Passager (Meadox, Oakland, Calif).
polyte
ssectio
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allograft 12 hours later. The case involved a patient who
developed hemoptysis after tracheal biopsy secondary to
puncture of the innominate artery by a tracheal ring. It is
interesting to note that all bacteriologic test results at the
time of the second operation (ie, explantation and open
repair) were negative.
In summary, on the basis of our findings, the use of
endovascular stents to control hemorrhage from carotid
blowout and tracheoinnominate fistula compares favorably
to other reported modalities of treatment for these disease
processes. Considering the nature of these lesions, infec-
tious complications are relatively infrequent but do occur.
Prolonged antibiotics may be of benefit, especially when
there is pharyngeal involvement. Recurrent bleeding epi-
Table I. Continued
Study Clinical history Bleeding site Sten
Chang et al11 52-y-old man with
squamous cell CA
of hypopharynx,
s/p XRT
Transpharyngeal
from L bulb
Wallgra
This study 51-y-old man with
laryngeal CA, s/p
ND, XRT, and
tracheostomy
Transcutaneous
from L CCA/
ECA
Viabah
61-y-old woman
with laryngeal
CA, s/p ND,
XRT, and
laryngectomy
Transcutaneous
from L CCA
Wallgra
78-y-old man with
laryngeal CA, s/p
ND, XRT, and
laryngectomy
Transcutaneous
from L CCA
Viabah
CA, Cancer; s/p, status post; ND, neck dissection; XRT, irradiation; R, rig
accident; ECA, external carotid artery; ICA, internal carotid artery; PTFE,
Table II. Endoluminal graft placement for tracheoinnom
Study Clinical history Stent
Deguchi et al12 37-y-old man with dysphagia after
resection and XRT of
medulloblastoma of the
cerebellum 14 y before
Passager
Wall et al13 47-y-old woman with metastatic
adenoid cystic CA to trachea/
lungs treated with XRT
Viabahn
Vianello et al14 16-y-old man with Duchenne
muscular dystrophy
Wallgraft
This study 22-y-old woman with severe
cerebral palsy
Wallgraft
77-y-old woman with anaplastic
thyroid CA, s/p , ND, XRT,
and tracheostomy
Wallgraft
XRT, Irradiation; s/p, status post; CA, cancer; NS, not stated; ND, neck disodes, conversely, are common, likely because of the ero-sive nature of these lesions, and extended coverage zones
should be considered.
Long-term survival in patients with cancer is severely
limited. Therefore, these procedures should be consid-
ered palliative. In that context, the short-term benefits of
this approach seem to warrant its use. In patients with
tracheoinnominate fistula after prolonged tracheostomy
for neurologic compromise, endografts seem to be du-
rable. However, the world experience with this approach
is small.
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